Response rate to hepatitis B vaccination in patients with chronic renal failure and end-stage-renal-disease: Influence of diabetes mellitus

Journal of Research in Medical Sciences

Volumn 10, Issue 6, 2005, Pages 384-390

  Taheri, Shahram ^a,b   Shahidi, Sh ^a   Moghtaderi, J ^a   Seirafian, Sh ^a   Emami, A ^a   Eftekhari, S M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Chronic renal failure; Diabetes mellitus; Dialysis; HBV vaccination

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PREDNISOLONE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; HEPATITIS B; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK ASSESSMENT; SEROCONVERSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 29244460378     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Shusterman N, Singer I. Infectious hepatitis in dialysis patients. Am J Kidney Dis 1987; 9:447-55.
2. Szmuness W, Stevens CE, Harley EJ, Zang E, Lolezco W, William D et al. Hepatitis B vaccination vaccine in medical staff of hemodialysis units efficacy and sub-type cross-protection. N Eng J Med 1982; 307:1481-6.
3. Rodby RA, Trenholme GM. Vaccination of the dialysis patient. Semin Dial 1991; 4:102-5.
4. Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 2001 Sep;15(3):813-32.
5. Maupas P, Goudeau A, Coursaget P, Drucker J, Bagros P, Baudin S et al. Vaccine against hepatitis B - 18 months prevention in a high risk setting. Med Microbiol Immunol (Berl) 1978 Nov 17;166(1-4):109-18.
6. Navarro JF, Teruel JL, Mateos ML, Marcen R, Ortuo J. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection. Am J Nephrol 1996; 16:95-7.
7. CDC. Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients. MMWR April 2001; 50(5):1-43.
8. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W et al (The Dialysis Vaccine Trial Study Group). Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med 1984;311:496-501.
9. Beleed K, Wright M, Eadington D, Farr M, Sellars L. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrand Med J 2002; 78:538-40.
10. Agarwal SK, Irshad M, Dash SC. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and sever renal failure. J Assoc Physicians India 1999; 47(2):183-5.
11. Seaworth B, Drucker J, Starling J, Drucker R, Stevens C, Hamilton J. Hepatitis B vaccine in patients with chronic renal failure before dialysis. J Infect Dis 1988; 157:332-7.
12. Dukes CS, Street AC, Starling JF, Hamilton JD. Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis. Vaccine 1993; 11:1229-32.
13. DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 2003 Dec;42(6):1184-92.
14. Peces R, de la Torre M, Alcazar R, Urra JM. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 1997 Feb;29(2):239-45.
15. Watkins SL, Alexander SR, Brewer ED, Hesley TM, West DJ, Chan IS et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 2002; 40(2):365-72.
16. Jadoul M, Goubau P. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clin Nephrol 2002; 58(4):301-4.
17. Chin AI. Hepatitis B virus vaccine response in hemodialysis: Baseline patient characteristics. Hemodial Int 2003; 7(4):296-303.
18. Tele SA, Martins RM, Lopes CL, dos Santos Carneiro MA, Souza KP, Yoshida CF. Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff. Eur J Epidemiol 2001; 17(2):145-9.
19. Michel P, Janin G, Chevallier P, Girard P, Laville M, Trepo C. Eradication of hepatitis B in dialysed patients through repeated sera vaccinations. Nephrologie 1986; 7(3):114-7.
20. Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine 2004; 22(29-30):3963-7.
21. Cheng CH, Huang CC, Leu MR, Chiang CY, Wu MS, Lai PC. Hepatitis B vaccine in hemodialysis patients with hepatitis C infection. Vaccine 1997; 15:1353-7.
22. Dacko C, Holley JL. The influence of nutritional status, dialysis adequacy, and residual function on the response to hepatitis B vaccination in peritoneal dialysis patients. Adv Perit Dial 1996; 12:315-8.
23. Fernandez E, Betriu MA, Gomez R, Montoliu J. Response to the hepatitis B virus vaccine in hemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996; 11(8):1559-63
24. Sezar S, Ozdemir FN, Guz G, Arat Z, Colak T, Sengul S et al. Factors influencing reponse to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc 2000; 32(3):607-8.
25. Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C et al. Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30(10):817-9.
26. Wismans PJ, van Hattum J, de Gast GC, Bouter KP, Diepersloot RJ, Maikoe T et al. A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls. J Med Virol 1991; 35(3):216-22.
27. Eibl N, Spatz M, Fischer GF, Mayr WR, Samstag A, Wolf HM et al. Impaired primary immune response in type-1 diabetes: Results from a controlled vaccination study. Clin Immunol 2002; 103(3 Part 1):249-59.
28. Geerlinge SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Micro 1999; 26:259-65.
29. Waite NM, Thomson LG, Goldstein MB. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 1995; 5(11):1930-4.
30. Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis B revaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 1997; 12(6):1204-11.
31. Singh NP, Mandal SK, Thakur A, Kapoor D, Anuradha S, Prakash A et al. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure - results of a prospective, randomized trial. Ren Fail 2003; 25(2):255-66.